Morphea
☆ I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
De ghnáth is cosúil le lot atrophic pigmented an lot Morphea.
References
Is galar annamh é Scleroderma a théann i bhfeidhm ar fhíocháin nascacha, ag taispeáint mar chraiceann cruaite agus uaireanta bíonn tionchar aige ar chodanna eile den chorp. Tá dhá phríomhchineál ann: systemic sclerosis , a bhaineann le hardening craicinn agus orgáin inmheánacha, agus localized scleroderma , ar a dtugtar morphea freisin, a fhanann de ghnáth teoranta don chraiceann agus d'fhíocháin faoina bhun, le cúrsa neamhurchóideach agus féin-theorannú. Cé go bhfuil scleroderma logánaithe neamhchoitianta agus nach bhfuil a chúis soiléir, tugann taighde le déanaí le fios go bhféadfadh tionchar a bheith aige freisin ar orgáin inmheánacha agus go bhféadfadh sé saincheisteanna sláinte éagsúla a bheith mar thoradh air. Tá cóireáil luath ríthábhachtach chun aimhréití a chosc, ag cur san áireamh tromchúiseacht fhéideartha localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Is galar uath-imdhíonachta neamhchoitianta é Morphea , ar a dtugtar scleroderma logánaithe freisin, a théann i bhfeidhm ar fhíochán nascach. Is féidir é a thaispeáint ar bhealaí éagsúla, agus níl sé an-choitianta, le thart ar 0. 4 - 2. 7 cás in aghaidh an 100,000 duine gach bliain. Is minic a fheictear Morphea i leanaí idir 2 agus 14 bliana d’aois, agus bíonn tionchar aige ar chailíní níos minice ná ar bhuachaillí.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Is galar an-annamh é morphea. Mar gheall ar chomhdhéanamh an ghrianghraif, seans go ndearna an t-algartam é a dhearmad mar morphea.